Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.900
-0.060 (-1.52%)
Dec 20, 2024, 4:00 PM EST - Market closed
Qualigen Therapeutics Employees
Qualigen Therapeutics had 4 employees as of December 31, 2023. The number of employees decreased by 34 or -89.47% compared to the previous year.
Employees
4
Change (1Y)
-34
Growth (1Y)
-89.47%
Revenue / Employee
n/a
Profits / Employee
-$1,985,305
Market Cap
2.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4 | -34 | -89.47% |
| Dec 31, 2022 | 38 | -8 | -17.39% |
| Dec 31, 2021 | 46 | 8 | 21.05% |
| Dec 31, 2020 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| iSpecimen | 53 |
| LogicMark | 27 |
| Petros Pharmaceuticals | 21 |
| Windtree Therapeutics | 20 |
| Onconetix | 12 |
| SCWorx | 7 |
| Artelo Biosciences | 6 |
| Titan Pharmaceuticals | 4 |
QLGN News
- 26 days ago - Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - GlobeNewsWire
- 7 weeks ago - Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewsWire
- 3 months ago - Qualigen Therapeutics, Inc. Announces management changes. - GlobeNewsWire
- 3 months ago - Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - GlobeNewsWire
- 3 months ago - Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - GlobeNewsWire
- 3 months ago - Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering - GlobeNewsWire
- 3 months ago - Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering - GlobeNewsWire
- 7 months ago - Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination - GlobeNewsWire